Actinium Pharmaceuticals Insider Trades

ATNM

Track insider trading activity from Actinium Pharmaceuticals executives and directors. See which insiders are buying and selling ATNM stock.

Trades Last 12 Months

All Insider Trades for Actinium Pharmaceuticals

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
David Matthew T Chief Financial Officer
Holding Value $358k 250,000 shares
Last Trade
Oct 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$487k 500,000 shares
$0.97
$1.43
Heeger Steffen Wilhem Chief Medical Officer
Holding Value $220k 153,868 shares
Last Trade
Sep 03, 2026 Sale
$288k 250,000 shares
$1.15
$1.43
Kamal Adeela Chief Scientific Officer
Holding Value $306k 213,648 shares
Last Trade
Sep 03, 2026 Sale
$120k 120,000 shares
$1.00
$1.43
Holding Value $135k 94,200 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 157,000 shares
$1.02
$1.43
Seth Sandesh Chief Executive Officer
Holding Value $2.81M 1,965,355 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.97M 2,911,274 shares
$1.02
$1.43
Chell Jeffrey W. Director
Holding Value $132k 92,400 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 154,000 shares
$1.02
$1.43
Holding Value $38.6k 27,000 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.9k 45,000 shares
$1.02
$1.43
Holding Value $135k 94,200 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 157,000 shares
$1.02
$1.43
Shetty Ajit Director
Holding Value $132k 92,400 shares
Last Trade
Sep 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 154,000 shares
$1.02
$1.43
Seth Sandesh Chief Executive Officer
Holding Value $264k 184,481 shares
Last Trade
Aug 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$207k 120,900 shares
$1.71
$1.43
O'loughlin Steve Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$413k 256,438 shares
$1.61
$1.43
O'loughlin Steve Chief Financial Officer
Holding Value $362k 253,123 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 253,123 shares
$5.00
$1.43
Berger Mark Stanley Chief Medical Officer
Holding Value $96k 67,164 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$408k 67,164 shares
$6.07
$1.43
Ludwig Dale L. Chief Science & Tech. Officer
Holding Value $71.5k 50,000 shares
Last Trade
Aug 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 50,000 shares
$9.55
$1.43
Kapur Anil Chief Commercial Officer
Holding Value $572k 400,000 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 400,000 shares
$6.96
$1.43
Ray Nitya G. Executive VP
Holding Value $107k 75,000 shares
Last Trade
Jul 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.76M 75,000 shares
$23.49
$1.43
Traversa Sergio Director
Holding Value $107k 75,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 75,000 shares
$41.70
$1.43
Cicic Dragan Chief Technology Officer
Holding Value $107k 75,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 75,000 shares
$41.70
$1.43
Dave Kaushik J CEO And Interim CFO
Holding Value $358k 250,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 250,000 shares
$41.70
$1.43
Holding Value $6.89M 4,821,226 shares
Last Trade
Aug 31, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.39M 136,853 shares
$54.00
$1.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up